CompletedNot Applicable

Evaluation of the Structured Caregiver Support Program (SCSP) in Terms of Various Parameters

Turkey (Türkiye)50 participantsStarted 2023-10-04

Plain-language summary

The aim of this clinical study is to examine the effect of an intervention program developed for informal caregivers of Alzheimer's patients on caregivers' burden of care, psychological well-being and psychological resilience.The main questions it aims to answer are: 1. What is the effect of the Structured Caregiver Support Program (SCSP) on caregivers burden? 2. What is the effect of the SCSP on psychological well-being? 3. What is the effect of the SCSP on psychological resilience? Participants (intervention group) will attend at least 6 sessions of an 8-session SCSP. Researchers will compare with the control group to see if the training provided is effective.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Providing informal care to an individual with mild or moderate Alzheimer's disease * Being a primary caregiver * Having been caring for the patient for at least 6 months * Providing care to the patient for at least 6 hours a day * The caregiver is 18 years or older * Residency of the caregiver in the province of Ankara * Willingness and volunteering to participate in the research Exclusion Criteria: * Hearing and understanding difficulties * Having a psychiatric disorder * Receiving any therapy services * Caregivers who did not attend two or more of the eight interviews were excluded.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Zarit Burden Interview

Timeframe: change from baseline to the end of the 8th week

Trial details

NCT IDNCT05990114

SponsorAkdeniz University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-22

View on ClinicalTrials.gov More Alzheimer Disease trials